$CRI

PIMCO discloses 1.89M-share Carter's Inc (CRI) position in Schedule 13G

Pacific Investment Management Company LLC (PIMCO) filed a Schedule 13G disclosing beneficial ownership of 1,890,588 shares of Carter’s Inc (CRI) common stock, or 5.1% of the class, based on 36,711,185 shares outstanding as of July 24, 2026. PIMCO reports sole voting and dispositive power over the shares.

Original reporting
Published Aug 6, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 10:54 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CRI
Neutral
medium confidence
Mentioned
$CRI
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CRINeutralLow
01

Why it matters

Traders may monitor whether this stake is increasing or accompanied by a 13D (active intent). As presented, it is a disclosure of ownership level and control rights, not a change in company fundamentals.

02

Market read

A new regulatory disclosure of a 5.1% beneficial ownership stake by PIMCO in CRI, which may influence positioning but lacks a direct fundamental catalyst.

03

What to watch

The filing does not state acquisition intent, cost basis, or whether the position is newly built versus previously held; without that, price impact is uncertain.

Relevance 4/10Novelty 4/10Timing: filing disclosed for the latest 13G period, dated with shares outstanding as of July 24, 2026

Background

The article summarizes a Schedule 13G filing by PIMCO reporting beneficial ownership in Carter’s Inc.

Company-level read

Ticker impact

$CRINeutralMedium confidence
Context

PIMCO filed a Schedule 13G showing beneficial ownership of 1,890,588 Carter’s Inc shares, or 5.1% of the float.

Expected impact

Likely limited near-term impact; any move would be sentiment/positioning-driven rather than fundamentals.

Evidence & confidence

A Schedule 13G is a regulatory disclosure of beneficial ownership. The article provides stake size and voting/dispositive control but no intent to change strategy, no transaction, and no fundamental update.

Market effects

Minimal. Large fund ownership disclosures are not sector-specific catalysts.

None indicated.

None indicated.

Counterpoint

A 13G can reflect passive or client-account holdings, so the stake may not translate into active influence or near-term trading pressure.

Key entities

  • Carter’s Inc

    Subject of the Schedule 13G beneficial ownership disclosure, with PIMCO reporting a 5.1% stake.

  • PIMCO

    Investment adviser filing the Schedule 13G and reporting sole voting and dispositive power over the disclosed shares.

Related articles

$CRIMedAI 8/10

Carter's (CRI) Q2 2026 Earnings Call Transcript

Carter’s (CRI) reported Q2 FY2026 net sales of $615.5 million, up 5.2%, with adjusted operating income of $18.1 million and adjusted diluted EPS of $0.26. U.S. retail comp sales rose 5.1%. The company recovered $132 million from tariff-related duties and revised FY2026 net sales guidance to 2% to 3% growth.

$CRIMed

Carter's: Q2 Earnings Snapshot

Carter’s Inc. (CRI) reported Q2 profit of $105 million, or $2.87 per share. Adjusted earnings were 26 cents per share. Revenue was $615.5 million. For the quarter ending September, the company expects EPS of 85 cents, and for fiscal Q3 revenue of $750 million.

$CRIHigh

CARTERS INC (CRI): Results of Operations and Financial Condition

CARTERS INC (CRI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cri-ex991q22026.htm EX-99.1 Document EXHIBIT 99.1 Contact: T.C. Robillard Vice President, Investor Relations tc.robillard@carters.com Carter ’ s, Inc. Reports Second Quarter Fiscal 2026 Results • Net sales $615 million vs. $585 million in Q2 2025; growth of 5% • U.S. Re

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).